Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael I Nishimura

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2015
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T CellsMariko Takami, Kotaro Fujimaki, Michael I Nishimura, et al.
Cancer Science|December 22, 2005
Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cellsShin-Ichiro Fujii, Michael I Nishimura, Michael T Lotze
Cytokine|June 11, 2018
Activated human Foxp3<sup>+</sup> regulatory T cells produce membrane-bound TNFAlexander Nelson, Christina Cunha, Michael I Nishimura, et al.
Self/Nonself|February 3, 2012
Adoptive immunotherapy of cancer: Gene transfer of T cell specificityAmir A Al-Khami, Shikhar Mehrotra, Michael I Nishimura
Journal of Leukocyte Biology|January 20, 2018
TCR modifications that enhance chain pairing in gene-modified T cells can augment cross-reactivity and alleviate CD8 dependenceTimothy T Spear, Kendra C Foley, Elizabeth Garrett-Mayer, et al.
Cancer Immunology, Immunotherapy : CII|October 10, 2019
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapyTimothy T Spear, Brian D Evavold, Brian M Baker, et al.
International Reviews of Immunology|May 15, 2003
Redirecting T lymphocyte specificity using T cell receptor genesBarbara L F Kaplan, David C Yu, Timothy M Clay, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccinationSimon Voelkl, Tamson V Moore, Michael Rehli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 24, 2017
Inducible Enhancement of T Cell Function and Anti-tumor Activity after Adoptive TransferJohn Wrangle, Chrystal M Paulos, Thomas W Smith, et al.
Vaccines|March 26, 2022
Genetic Modification of T Cells for the Immunotherapy of CancerSuzanne Quinn, Natasha Lenart, Victoria Dronzek, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2015
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T CellsMariko Takami, Kotaro Fujimaki, Michael I Nishimura, et al.
Cancer Science|December 22, 2005
Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cellsShin-Ichiro Fujii, Michael I Nishimura, Michael T Lotze
Cytokine|June 11, 2018
Activated human Foxp3<sup>+</sup> regulatory T cells produce membrane-bound TNFAlexander Nelson, Christina Cunha, Michael I Nishimura, et al.
Self/Nonself|February 3, 2012
Adoptive immunotherapy of cancer: Gene transfer of T cell specificityAmir A Al-Khami, Shikhar Mehrotra, Michael I Nishimura
Journal of Leukocyte Biology|January 20, 2018
TCR modifications that enhance chain pairing in gene-modified T cells can augment cross-reactivity and alleviate CD8 dependenceTimothy T Spear, Kendra C Foley, Elizabeth Garrett-Mayer, et al.
Cancer Immunology, Immunotherapy : CII|October 10, 2019
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapyTimothy T Spear, Brian D Evavold, Brian M Baker, et al.
International Reviews of Immunology|May 15, 2003
Redirecting T lymphocyte specificity using T cell receptor genesBarbara L F Kaplan, David C Yu, Timothy M Clay, et al.
Cancer Immunology, Immunotherapy : CII|October 7, 2008
Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccinationSimon Voelkl, Tamson V Moore, Michael Rehli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 24, 2017
Inducible Enhancement of T Cell Function and Anti-tumor Activity after Adoptive TransferJohn Wrangle, Chrystal M Paulos, Thomas W Smith, et al.
Vaccines|March 26, 2022
Genetic Modification of T Cells for the Immunotherapy of CancerSuzanne Quinn, Natasha Lenart, Victoria Dronzek, et al.
Pageof 10